gastric cancer
Conditions
Interventions
administration of two packs (480 ml) daily of Prosure for 6 month
Sponsors
Nutrition on Cancer Chemotherapy Conference
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - advanced, recurrent, or R1 or R2 post operative gastric cancer - first-line chemotherapy - written informed consent obtained from patients or or legal representatives - male or female of 20 - 80 years-old at informed consent - ability of oral intake and maintained gastrointestinal function - estimated prognosis longer than three months (PS0 - 2) - albumin<3.5g/dl and CRP>=0.5mg/dl - assured tolerance to Prosure at pre-interventional test
Exclusion criteria
Exclusion criteria: - intestinal obstruction (inability of oral intake) - obvious infection focus - severe heart, liver, or kidney disease - uncontrollable diabetes mellitus - hyperlipidemia resistant to treatment - past history of chronic inflammatory disease - past history of allergy to contents of Prosure (milk, soybean etc) - probable pregnancy and/or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| time to treatment failure (TTF) of a first-line chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival progression free survival nutritional assessment (serum CRP,serum albumin,detachment rate form group D,TLC,body weight,BMI) QOL(Quality of life) comparison with a control group | — |
Countries
Japan
Contacts
Public ContactHiroshi Imamura
Sakai City Hospital Surgery
Outcome results
None listed